Vitrolife
Fr├╢lunda
About Vitrolife
Vitrolife is a biotechnology company that develops products to counter fertility issues in humans. The company also develops various media that enable researchers and cell therapy companies to use cells for therapeutic purposes. Vitrolife was founded in 1994 and is based in Frolunda, Sweden with subsidiaries in USA, Hungary, Australia, France, Italy, United Kingdom, and Japan
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $100K – $500K
- Total funding: $354.2M
- Funding stage: IPO
- Last round: Post-IPO Debt (Jul 2025)
- Ticker: sto:VITR
- Website: vitrolife.com
- Phone: +46 31 721 81 00
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/vitrolife-101555 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.